In another study [176], a CSC-like phenotype was induced in hepatocellular carcinoma cells by selecting for a cell population resistant to the ant-cancer drug sorafenib; the resulting cells had impaired AMPK signalling and increased expression of stem cell markers. Here, PRKAB1 is linked to cancer.